Morawski M, Schilling S, Kreuzberger M, Waniek A, Jäger C, Koch B, et al. Glutaminyl cyclase in human cortex: correlation with (pGlu)-amyloid-? load and cognitive decline in Alzheimer's disease. J Alzheimers Dis. 2014;39:385-400 pubmed publisher

Becker A, Kohlmann S, Alexandru A, Jagla W, Canneva F, B uscher C, et al. Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration. BMC Neurosci. 2013;14:108 pubmed publisher

Nussbaum J, Schilling S, Cynis H, Silva A, Swanson E, Wangsanut T, et al. Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-?. Nature. 2012;485:651-5 pubmed publisher

Morawski M, Brückner G, Jäger C, Seeger G, Matthews R, Arendt T. Involvement of perineuronal and perisynaptic extracellular matrix in Alzheimer's disease neuropathology. Brain Pathol. 2012;22:547-61 pubmed publisher

Alexandru A, Jagla W, Graubner S, Becker A, Bäuscher C, Kohlmann S, et al. Selective hippocampal neurodegeneration in transgenic mice expressing small amounts of truncated A? is induced by pyroglutamate-A? formation. J Neurosci. 2011;31:12790-801 pubmed publisher

Hartlage Rübsamen M, Morawski M, Waniek A, Jäger C, Zeitschel U, Koch B, et al. Glutaminyl cyclase contributes to the formation of focal and diffuse pyroglutamate (pGlu)-A? deposits in hippocampus via distinct cellular mechanisms. Acta Neuropathol. 2011;121:705-19 pubmed publisher